Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Immunotherapy for glioblastoma: Quo vadis?

Date

09 Oct 2016

Session

Moving steps forward: What’s new in the treatment of brain tumours

Presenters

Michael Weller

Authors

M. Weller

Author affiliations

Department Of Neurology, Universitätsspital Zürich, 8091 - Zürich/CH

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

09 Oct 2016

Identifying and overcoming challenges in immunotherapy for brain tumours: The iRANO approach

Presenter: Patrick Wen

Session: Moving steps forward: What’s new in the treatment of brain tumours

Resources:

Presentation

Webcast

09 Oct 2016

How can we deal with the toxicity of new agents?

Presenter: Deborah Blumenthal, MD

Session: Moving steps forward: What’s new in the treatment of brain tumours

Resources:

Presentation

Webcast

09 Oct 2016

Conclusions and clinical perspectives

Presenter: Patrick Wen

Session: Moving steps forward: What’s new in the treatment of brain tumours

Resources:

Presentation

Webcast